Michael V. Greco
General Counsel presso RALLYBIO CORPORATION
Profilo
Michael V.
Greco is currently the Head-Legal at Rallybio Corp.
He previously worked as a Director at Synageva BioPharma Corp.
and as an Attorney at BMC Partners LLP and Wiggin & Dana LLP.
From 2014 to 2018, he was the Secretary & Senior Vice President-Law at Alexion Pharmaceuticals, Inc. He also served as the Secretary & General Counsel at Springworks Therapeutics, Inc. from 2018 to 2019.
Greco received his undergraduate degree from the US Military Academy and his graduate degree from Suffolk University Law School.
Posizioni attive di Michael V. Greco
Società | Posizione | Inizio |
---|---|---|
RALLYBIO CORPORATION | General Counsel | - |
Precedenti posizioni note di Michael V. Greco
Società | Posizione | Fine |
---|---|---|
SPRINGWORKS THERAPEUTICS, INC. | General Counsel | 01/10/2019 |
ALEXION PHARMACEUTICALS, INC. | General Counsel | 01/06/2018 |
Wiggin & Dana LLP
Wiggin & Dana LLP Miscellaneous Commercial ServicesCommercial Services Wiggin & Dana LLP provides legal services. The firm’s client includes publicly traded companies, hospitals and other health care organizations, universities, entrepreneurs and emerging growth companies, real estate developers, financial institutions, museums, and charitable organizations and individuals. The company was founded in 1934 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 01/02/2007 |
BMC Partners LLP
BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/05/2005 |
SYNAGEVA BIOPHARMA CORP | Director/Board Member | - |
Formazione di Michael V. Greco
US Military Academy | Undergraduate Degree |
Suffolk University Law School | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
SPRINGWORKS THERAPEUTICS, INC. | Health Technology |
RALLYBIO CORPORATION | Health Technology |
Aziende private | 4 |
---|---|
Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
BMC Partners LLP
BMC Partners LLP Miscellaneous Commercial ServicesCommercial Services BMC Partners LLP provides litigation, corporate, finance, restructuring, employment and benefits, and intellectual property services in all industries. It also offers consulting and advisory services in government, investment management, and mergers and acquisitions. The company was founded on July 1, 2002 and is headquartered in Boston, MA. | Commercial Services |
Wiggin & Dana LLP
Wiggin & Dana LLP Miscellaneous Commercial ServicesCommercial Services Wiggin & Dana LLP provides legal services. The firm’s client includes publicly traded companies, hospitals and other health care organizations, universities, entrepreneurs and emerging growth companies, real estate developers, financial institutions, museums, and charitable organizations and individuals. The company was founded in 1934 and is headquartered in New Haven, CT. | Commercial Services |
Synageva BioPharma Corp.
Synageva BioPharma Corp. BiotechnologyHealth Technology Synageva BioPharma Corp. is a biopharmaceutical company which focuses on the discovery, development, and commercialization of therapeutic products for patients with life-threatening rare diseases and high unmet medical need. The company is currently evaluating sebelipase alfa in global clinical trials for LAL Deficiency, a lysosomal storage disease associated with liver damage and accelerated atherosclerosis in children and adults, and in infants, premature death often before six months of age. Synageva BioPharma was founded in 1993 and is headquartered in Lexington, MA. | Health Technology |
- Borsa valori
- Insiders
- Michael V. Greco